An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0272260
PubMed Identifier: 36067162
Publication URI: http://europepmc.org/abstract/MED/36067162
Type: Journal Article/Review
Volume: 17
Parent Publication: PloS one
Issue: 9
ISSN: 1932-6203